425 related articles for article (PubMed ID: 36623520)
41. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status.
Xie Y; Bowe B; Al-Aly Z
Nat Commun; 2021 Nov; 12(1):6571. PubMed ID: 34772922
[TBL] [Abstract][Full Text] [Related]
42. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
Nordström P; Ballin M; Nordström A
Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
[TBL] [Abstract][Full Text] [Related]
43. Postacute sequelae of COVID-19 at 2 years.
Bowe B; Xie Y; Al-Aly Z
Nat Med; 2023 Sep; 29(9):2347-2357. PubMed ID: 37605079
[TBL] [Abstract][Full Text] [Related]
44. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
45. Youth Mental Health Outcomes up to Two Years After SARS-CoV-2 Infection Long-COVID or Long-Pandemic Syndrome: A Retrospective Cohort Study.
Bilu Y; Flaks-Manov N; Goldshtein I; Bivas-Benita M; Akiva P; Bodenheimer G; Greenfeld S
J Adolesc Health; 2023 Oct; 73(4):701-706. PubMed ID: 37389526
[TBL] [Abstract][Full Text] [Related]
46. Prophylactic anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
[TBL] [Abstract][Full Text] [Related]
47. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
[TBL] [Abstract][Full Text] [Related]
48. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study.
Lund LC; Hallas J; Nielsen H; Koch A; Mogensen SH; Brun NC; Christiansen CF; Thomsen RW; Pottegård A
Lancet Infect Dis; 2021 Oct; 21(10):1373-1382. PubMed ID: 33984263
[TBL] [Abstract][Full Text] [Related]
49. Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER program.
Varma JK; Zang C; Carton TW; Block JP; Khullar DJ; Zhang Y; Weiner MG; Rothman RL; Schenck EJ; Xu Z; Lyman K; Bian J; Xu J; Shenkman EA; Maughan C; Castro-Baucom L; O'Brien L; Wang F; Kaushal R;
PLoS One; 2024; 19(6):e0282451. PubMed ID: 38843159
[TBL] [Abstract][Full Text] [Related]
50. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
[TBL] [Abstract][Full Text] [Related]
51. Risk of Incident Thyroid Dysfunction in the Post-Acute Phase of COVID-19: A Population-Based Cohort Study in Hong Kong.
Lui DTW; Xiong X; Cheung CL; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Li L; Chung MSH; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
Endocr Pract; 2024 Jun; 30(6):528-536. PubMed ID: 38552902
[TBL] [Abstract][Full Text] [Related]
52. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
[TBL] [Abstract][Full Text] [Related]
53. Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank.
Wan EYF; Mathur S; Zhang R; Yan VKC; Lai FTT; Chui CSL; Li X; Wong CKH; Chan EWY; Yiu KH; Wong ICK
Cardiovasc Res; 2023 Jul; 119(8):1718-1727. PubMed ID: 36652991
[TBL] [Abstract][Full Text] [Related]
54. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
55. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
56. Outcomes of SARS-CoV-2-Positive Youths Tested in Emergency Departments: The Global PERN-COVID-19 Study.
Funk AL; Florin TA; Kuppermann N; Tancredi DJ; Xie J; Kim K; Neuman MI; Ambroggio L; Plint AC; Mintegi S; Klassen TP; Salvadori MI; Malley R; Payne DC; Simon NJ; Yock-Corrales A; Nebhrajani JR; Chaudhari PP; Breslin KA; Finkelstein Y; Campos C; Bergmann KR; Bhatt M; Ahmad FA; Gardiner MA; Avva UR; Shah NP; Sartori LF; Sabhaney VJ; Caperell K; Navanandan N; Borland ML; Morris CR; Gangoiti I; Pavlicich V; Kannikeswaran N; Lunoe MM; Rino PB; Kam AJ; Cherry JC; Rogers AJ; Chong SL; Palumbo L; Angelats CM; Morrison AK; Kwok MY; Becker SM; Dixon AC; Poonai N; Eckerle M; Wassem M; Dalziel SR; Freedman SB;
JAMA Netw Open; 2022 Jan; 5(1):e2142322. PubMed ID: 35015063
[TBL] [Abstract][Full Text] [Related]
57. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study.
Dryden M; Mudara C; Vika C; Blumberg L; Mayet N; Cohen C; Tempia S; Parker A; Nel J; Perumal R; Groome MJ; Conradie F; Ndjeka N; Sigfrid L; Merson L; Jassat W
Lancet Glob Health; 2022 Sep; 10(9):e1247-e1256. PubMed ID: 35961348
[TBL] [Abstract][Full Text] [Related]
58. Rates of ICD-10 Code U09.9 Documentation and Clinical Characteristics of VA Patients With Post-COVID-19 Condition.
Wander PL; Baraff A; Fox A; Cho K; Maripuri M; Honerlaw JP; Ho YL; Dey AT; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Viglianti E; Iwashyna TJ; Hynes DM; Osborne TF; Ioannou GN
JAMA Netw Open; 2023 Dec; 6(12):e2346783. PubMed ID: 38064215
[TBL] [Abstract][Full Text] [Related]
59. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
